Location History:
- Rhode-Saint-Genese, BE (2002 - 2005)
- Rixensart, BE (2005 - 2010)
Company Filing History:
5 out of 75 
5 out of 531 
Years Active: 2002-2010
Title: The Innovative Contributions of Martine Anne Cecile Wettendorff
Introduction
Martine Anne Cecile Wettendorff is a prominent inventor based in Rixensart, Belgium. She has made significant contributions to the field of biotechnology, particularly in the development of vaccines. With a total of 10 patents to her name, her work has had a profound impact on public health.
Latest Patents
One of her latest patents focuses on a vaccine that pertains to methods for treating infections caused by human papillomaviruses (HPV). This invention highlights the importance of immunization with HPV16 and HPV18 virus-like particles, which provide cross-protection against other HPV types. Another notable patent involves a vaccine composition that comprises virus-like particles (VLPs) containing L1 proteins or functional L1 protein derivatives from HPV 16, HPV 18, HPV 31, and HPV 45 genotypes. These innovations are crucial in the fight against HPV-related diseases.
Career Highlights
Throughout her career, Martine has worked with leading companies in the biotechnology sector, including SmithKline Beecham Biologicals S.A. and GlaxoSmithKline Biologicals S.A. Her expertise and dedication have positioned her as a key figure in vaccine research and development.
Collaborations
Martine has collaborated with notable professionals in her field, including Jean Stephenne and Gary Dubin. These partnerships have further enhanced her research and contributed to her success as an inventor.
Conclusion
Martine Anne Cecile Wettendorff's innovative work in vaccine development has made her a significant contributor to the field of biotechnology. Her patents and collaborations reflect her commitment to improving public health through scientific advancements.